nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—NR3C1—glaucoma	0.829	1	CbGaD
Fluoxymesterone—Hirsutism—Bimatoprost—glaucoma	0.00467	0.0496	CcSEcCtD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—TXN—glaucoma	0.00466	0.069	CbGpPWpGaD
Fluoxymesterone—PRLR—Ovarian Infertility Genes—CCND2—glaucoma	0.00399	0.0591	CbGpPWpGaD
Fluoxymesterone—Seborrhoeic dermatitis—Pilocarpine—glaucoma	0.00318	0.0338	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Acetazolamide—glaucoma	0.00285	0.0303	CcSEcCtD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—POU4F2—glaucoma	0.00235	0.0349	CbGpPWpGaD
Fluoxymesterone—Libido decreased—Apraclonidine—glaucoma	0.00219	0.0233	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—PITX2—glaucoma	0.00217	0.0322	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Dipivefrin—glaucoma	0.00202	0.0214	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Apraclonidine—glaucoma	0.00202	0.0214	CcSEcCtD
Fluoxymesterone—Nausea—Physostigmine—glaucoma	0.00191	0.0203	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Acetazolamide—glaucoma	0.00188	0.0199	CcSEcCtD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—CAV1—glaucoma	0.00188	0.0278	CbGpPWpGaD
Fluoxymesterone—PRLR—Ovarian Infertility Genes—CDKN1B—glaucoma	0.00181	0.0268	CbGpPWpGaD
Fluoxymesterone—Libido decreased—Dorzolamide—glaucoma	0.0018	0.0191	CcSEcCtD
Fluoxymesterone—Libido decreased—Brinzolamide—glaucoma	0.00177	0.0188	CcSEcCtD
Fluoxymesterone—Alopecia—Levobunolol—glaucoma	0.00167	0.0178	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Dorzolamide—glaucoma	0.00165	0.0176	CcSEcCtD
Fluoxymesterone—ESR1—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.00164	0.0243	CbGpPWpGaD
Fluoxymesterone—Disturbance in sexual arousal—Brinzolamide—glaucoma	0.00162	0.0173	CcSEcCtD
Fluoxymesterone—Anxiety—Metipranolol—glaucoma	0.0016	0.017	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Clonidine—glaucoma	0.00155	0.0165	CcSEcCtD
Fluoxymesterone—Haemorrhage—Apraclonidine—glaucoma	0.00141	0.0149	CcSEcCtD
Fluoxymesterone—Libido decreased—Clonidine—glaucoma	0.00136	0.0144	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Methazolamide—glaucoma	0.00129	0.0137	CcSEcCtD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—POU4F1—glaucoma	0.00129	0.0191	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00127	0.0189	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Diclofenamide—glaucoma	0.00126	0.0134	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Clonidine—glaucoma	0.00125	0.0132	CcSEcCtD
Fluoxymesterone—Paraesthesia—Levobunolol—glaucoma	0.00121	0.0128	CcSEcCtD
Fluoxymesterone—ESR1—LKB1 signaling events—RPTOR—glaucoma	0.0012	0.0177	CbGpPWpGaD
Fluoxymesterone—Libido decreased—Betaxolol—glaucoma	0.00118	0.0125	CcSEcCtD
Fluoxymesterone—Paraesthesia—Methazolamide—glaucoma	0.00116	0.0123	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Metipranolol—glaucoma	0.00113	0.012	CcSEcCtD
Fluoxymesterone—ESR1—Signaling events mediated by HDAC Class II—HDAC9—glaucoma	0.00109	0.0161	CbGpPWpGaD
Fluoxymesterone—Disturbance in sexual arousal—Betaxolol—glaucoma	0.00109	0.0115	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00108	0.0161	CbGpPWpGaD
Fluoxymesterone—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—glaucoma	0.00107	0.0159	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Carteolol—glaucoma	0.00105	0.0112	CcSEcCtD
Fluoxymesterone—PRLR—Adipogenesis—NR3C1—glaucoma	0.00102	0.0152	CbGpPWpGaD
Fluoxymesterone—Alopecia—Dorzolamide—glaucoma	0.00102	0.0108	CcSEcCtD
Fluoxymesterone—Anxiety—Bimatoprost—glaucoma	0.00101	0.0107	CcSEcCtD
Fluoxymesterone—Alopecia—Brinzolamide—glaucoma	0.001	0.0106	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Levobunolol—glaucoma	0.000992	0.0105	CcSEcCtD
Fluoxymesterone—PRLR—Adipogenesis—FAS—glaucoma	0.000991	0.0147	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000967	0.0143	CbGpPWpGaD
Fluoxymesterone—Libido decreased—Timolol—glaucoma	0.000964	0.0102	CcSEcCtD
Fluoxymesterone—Headache—Metipranolol—glaucoma	0.000964	0.0102	CcSEcCtD
Fluoxymesterone—Alopecia—Pilocarpine—glaucoma	0.000962	0.0102	CcSEcCtD
Fluoxymesterone—Nausea—Metipranolol—glaucoma	0.000914	0.00971	CcSEcCtD
Fluoxymesterone—Paraesthesia—Apraclonidine—glaucoma	0.000896	0.00952	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Acetazolamide—glaucoma	0.000893	0.00949	CcSEcCtD
Fluoxymesterone—Headache—Carteolol—glaucoma	0.000893	0.00949	CcSEcCtD
Fluoxymesterone—Anxiety—Brimonidine—glaucoma	0.000891	0.00947	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Timolol—glaucoma	0.000887	0.00942	CcSEcCtD
Fluoxymesterone—Headache—Diclofenamide—glaucoma	0.000878	0.00933	CcSEcCtD
Fluoxymesterone—Headache—Carbachol—glaucoma	0.000857	0.0091	CcSEcCtD
Fluoxymesterone—Anxiety—Dorzolamide—glaucoma	0.000851	0.00904	CcSEcCtD
Fluoxymesterone—Anxiety—Travoprost—glaucoma	0.000847	0.009	CcSEcCtD
Fluoxymesterone—Nausea—Carteolol—glaucoma	0.000847	0.00899	CcSEcCtD
Fluoxymesterone—Headache—Levobunolol—glaucoma	0.000844	0.00896	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000835	0.0124	CbGpPWpGaD
Fluoxymesterone—Nausea—Diclofenamide—glaucoma	0.000832	0.00884	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Dorzolamide—glaucoma	0.000819	0.0087	CcSEcCtD
Fluoxymesterone—Nausea—Carbachol—glaucoma	0.000812	0.00863	CcSEcCtD
Fluoxymesterone—Headache—Methazolamide—glaucoma	0.000808	0.00859	CcSEcCtD
Fluoxymesterone—Anxiety—Pilocarpine—glaucoma	0.000804	0.00854	CcSEcCtD
Fluoxymesterone—Paraesthesia—Acetazolamide—glaucoma	0.000802	0.00852	CcSEcCtD
Fluoxymesterone—Nausea—Levobunolol—glaucoma	0.0008	0.0085	CcSEcCtD
Fluoxymesterone—Headache—Latanoprost—glaucoma	0.000782	0.00831	CcSEcCtD
Fluoxymesterone—Paraesthesia—Brimonidine—glaucoma	0.00077	0.00818	CcSEcCtD
Fluoxymesterone—Alopecia—Clonidine—glaucoma	0.000768	0.00816	CcSEcCtD
Fluoxymesterone—Nausea—Methazolamide—glaucoma	0.000766	0.00814	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—BAD—glaucoma	0.000748	0.0111	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Apraclonidine—glaucoma	0.000736	0.00782	CcSEcCtD
Fluoxymesterone—Paraesthesia—Dorzolamide—glaucoma	0.000735	0.00781	CcSEcCtD
Fluoxymesterone—Paraesthesia—Brinzolamide—glaucoma	0.000723	0.00768	CcSEcCtD
Fluoxymesterone—AR—FOXA1 transcription factor network—SOD1—glaucoma	0.000715	0.0106	CbGpPWpGaD
Fluoxymesterone—Desoximetasone—NR3C1—glaucoma	0.000703	0.0761	CrCbGaD
Fluoxymesterone—Loteprednol—NR3C1—glaucoma	0.000695	0.0752	CrCbGaD
Fluoxymesterone—Paraesthesia—Pilocarpine—glaucoma	0.000695	0.00738	CcSEcCtD
Fluoxymesterone—Alopecia—Betaxolol—glaucoma	0.000669	0.00711	CcSEcCtD
Fluoxymesterone—AR—Nuclear Receptors—NR3C1—glaucoma	0.000667	0.00988	CbGpPWpGaD
Fluoxymesterone—Anxiety—Clonidine—glaucoma	0.000642	0.00682	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Brimonidine—glaucoma	0.000631	0.00671	CcSEcCtD
Fluoxymesterone—Headache—Apraclonidine—glaucoma	0.000625	0.00665	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—LRP12—glaucoma	0.000616	0.00913	CbGpPWpGaD
Fluoxymesterone—Headache—Bimatoprost—glaucoma	0.000606	0.00644	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Dorzolamide—glaucoma	0.000603	0.00641	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL1A—glaucoma	0.000602	0.00891	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Travoprost—glaucoma	0.0006	0.00638	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000596	0.00883	CbGpPWpGaD
Fluoxymesterone—Hydrocortamate—NR3C1—glaucoma	0.000595	0.0645	CrCbGaD
Fluoxymesterone—PRLR—Immune System—CTSA—glaucoma	0.000595	0.00881	CbGpPWpGaD
Fluoxymesterone—Nausea—Apraclonidine—glaucoma	0.000593	0.0063	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Brinzolamide—glaucoma	0.000593	0.0063	CcSEcCtD
Fluoxymesterone—Cortisone acetate—NR3C1—glaucoma	0.000586	0.0635	CrCbGaD
Fluoxymesterone—Nausea—Bimatoprost—glaucoma	0.000575	0.00611	CcSEcCtD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—TGFB2—glaucoma	0.000575	0.00851	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Pilocarpine—glaucoma	0.00057	0.00605	CcSEcCtD
Fluoxymesterone—Megestrol acetate—NR3C1—glaucoma	0.000565	0.0612	CrCbGaD
Fluoxymesterone—Headache—Acetazolamide—glaucoma	0.000559	0.00594	CcSEcCtD
Fluoxymesterone—Anxiety—Betaxolol—glaucoma	0.000559	0.00594	CcSEcCtD
Fluoxymesterone—Paraesthesia—Clonidine—glaucoma	0.000555	0.00589	CcSEcCtD
Fluoxymesterone—Amcinonide—NR3C1—glaucoma	0.000554	0.0599	CrCbGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—SOD1—glaucoma	0.000551	0.00816	CbGpPWpGaD
Fluoxymesterone—Alopecia—Timolol—glaucoma	0.000546	0.00581	CcSEcCtD
Fluoxymesterone—Headache—Brimonidine—glaucoma	0.000537	0.00571	CcSEcCtD
Fluoxymesterone—Nausea—Acetazolamide—glaucoma	0.00053	0.00564	CcSEcCtD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000527	0.00781	CbGpPWpGaD
Fluoxymesterone—Mometasone—NR3C1—glaucoma	0.000527	0.057	CrCbGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—CDKN1B—glaucoma	0.000521	0.00772	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling events mediated by HDAC Class II—NR3C1—glaucoma	0.000514	0.00761	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptors—NR3C1—glaucoma	0.000514	0.00761	CbGpPWpGaD
Fluoxymesterone—Headache—Dorzolamide—glaucoma	0.000513	0.00545	CcSEcCtD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.000511	0.00757	CbGpPWpGaD
Fluoxymesterone—Headache—Travoprost—glaucoma	0.000511	0.00542	CcSEcCtD
Fluoxymesterone—Nausea—Brimonidine—glaucoma	0.000509	0.00541	CcSEcCtD
Fluoxymesterone—Headache—Brinzolamide—glaucoma	0.000504	0.00536	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—TXNIP—glaucoma	0.000501	0.00742	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—TBK1—glaucoma	0.000491	0.00727	CbGpPWpGaD
Fluoxymesterone—Nausea—Dorzolamide—glaucoma	0.000486	0.00517	CcSEcCtD
Fluoxymesterone—Headache—Pilocarpine—glaucoma	0.000485	0.00515	CcSEcCtD
Fluoxymesterone—Nausea—Travoprost—glaucoma	0.000484	0.00514	CcSEcCtD
Fluoxymesterone—Paraesthesia—Betaxolol—glaucoma	0.000483	0.00513	CcSEcCtD
Fluoxymesterone—Nausea—Brinzolamide—glaucoma	0.000478	0.00508	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—glaucoma	0.000467	0.00692	CbGpPWpGaD
Fluoxymesterone—Fludrocortisone—NR3C1—glaucoma	0.000465	0.0503	CrCbGaD
Fluoxymesterone—Clobetasol propionate—NR3C1—glaucoma	0.000465	0.0503	CrCbGaD
Fluoxymesterone—Nausea—Pilocarpine—glaucoma	0.000459	0.00488	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000457	0.00676	CbGpPWpGaD
Fluoxymesterone—Anxiety—Timolol—glaucoma	0.000457	0.00485	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Clonidine—glaucoma	0.000455	0.00484	CcSEcCtD
Fluoxymesterone—Fluorometholone—NR3C1—glaucoma	0.000448	0.0485	CrCbGaD
Fluoxymesterone—PRLR—Immune System—C1QB—glaucoma	0.000444	0.00658	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Timolol—glaucoma	0.000439	0.00467	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—OPN4—glaucoma	0.000427	0.00633	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—TNF—glaucoma	0.000421	0.00623	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000415	0.00614	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—glaucoma	0.000408	0.00604	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000406	0.00601	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HEYL—glaucoma	0.000397	0.00588	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Betaxolol—glaucoma	0.000396	0.00421	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—TXN—glaucoma	0.000396	0.00586	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Timolol—glaucoma	0.000394	0.00419	CcSEcCtD
Fluoxymesterone—Headache—Clonidine—glaucoma	0.000387	0.00411	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—PTGFR—glaucoma	0.000385	0.0057	CbGpPWpGaD
Fluoxymesterone—Nausea—Clonidine—glaucoma	0.000367	0.0039	CcSEcCtD
Fluoxymesterone—Triamcinolone—NR3C1—glaucoma	0.000365	0.0395	CrCbGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.000364	0.00539	CbGpPWpGaD
Fluoxymesterone—Spironolactone—NR3C1—glaucoma	0.000351	0.038	CrCbGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000346	0.00513	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—EDN1—glaucoma	0.000345	0.0051	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—MMP2—glaucoma	0.000344	0.00509	CbGpPWpGaD
Fluoxymesterone—AR—FOXA1 transcription factor network—CDKN1B—glaucoma	0.000342	0.00507	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—EDN1—glaucoma	0.000339	0.00503	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—MMP2—glaucoma	0.000337	0.005	CbGpPWpGaD
Fluoxymesterone—Headache—Betaxolol—glaucoma	0.000337	0.00358	CcSEcCtD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—glaucoma	0.000334	0.00495	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—BCL2L1—glaucoma	0.00033	0.00489	CbGpPWpGaD
Fluoxymesterone—Medroxyprogesterone Acetate—NR3C1—glaucoma	0.000329	0.0356	CrCbGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000327	0.00484	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—CDKN1B—glaucoma	0.000325	0.00481	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Timolol—glaucoma	0.000324	0.00344	CcSEcCtD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.000323	0.00479	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—TNF—glaucoma	0.000322	0.00477	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—NOS3—glaucoma	0.000322	0.00477	CbGpPWpGaD
Fluoxymesterone—Progesterone—CYP1B1—glaucoma	0.00032	0.0346	CrCbGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.00032	0.00473	CbGpPWpGaD
Fluoxymesterone—Nausea—Betaxolol—glaucoma	0.000319	0.00339	CcSEcCtD
Fluoxymesterone—ESR1—AP-1 transcription factor network—NR3C1—glaucoma	0.000315	0.00467	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000315	0.00466	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CDKN2A—glaucoma	0.000309	0.00458	CbGpPWpGaD
Fluoxymesterone—Prednisolone—NR3C1—glaucoma	0.000305	0.033	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000304	0.0045	CbGpPWpGaD
Fluoxymesterone—Testosterone—CYP1B1—glaucoma	0.000302	0.0327	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—RPTOR—glaucoma	0.000301	0.00446	CbGpPWpGaD
Fluoxymesterone—Betamethasone—NR3C1—glaucoma	0.000299	0.0324	CrCbGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CDKN2A—glaucoma	0.000298	0.00441	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CAV1—glaucoma	0.000297	0.00441	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP1B1—glaucoma	0.000292	0.0317	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—NCK2—glaucoma	0.000291	0.00432	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MMP1—glaucoma	0.00029	0.00429	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MMP1—glaucoma	0.000285	0.00422	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.00028	0.00415	CbGpPWpGaD
Fluoxymesterone—Headache—Timolol—glaucoma	0.000275	0.00292	CcSEcCtD
Fluoxymesterone—ESR1—Leptin signaling pathway—BCL2L1—glaucoma	0.000273	0.00404	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000269	0.00398	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—CDKN1B—glaucoma	0.000264	0.00391	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—glaucoma	0.000261	0.00387	CbGpPWpGaD
Fluoxymesterone—Nausea—Timolol—glaucoma	0.000261	0.00277	CcSEcCtD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—MMP9—glaucoma	0.000258	0.00383	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—MMP2—glaucoma	0.000257	0.00381	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000254	0.00377	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—glaucoma	0.000251	0.00372	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000248	0.00367	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HDAC9—glaucoma	0.000248	0.00367	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—BAD—glaucoma	0.000247	0.00366	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000244	0.00361	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—glaucoma	0.00024	0.00355	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000234	0.00347	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000234	0.00347	CbGpPWpGaD
Fluoxymesterone—Hydrocortisone—NR3C1—glaucoma	0.000233	0.0253	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000227	0.00336	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—NGF—glaucoma	0.000217	0.00321	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000216	0.00319	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000212	0.00313	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000209	0.00309	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000207	0.00307	CbGpPWpGaD
Fluoxymesterone—Triamcinolone—PTGS2—glaucoma	0.000207	0.0224	CrCbGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CDKN2A—glaucoma	0.000205	0.00304	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000203	0.00301	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CDKN2A—glaucoma	0.000202	0.003	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000199	0.00295	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—NOS3—glaucoma	0.000199	0.00294	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL1A—glaucoma	0.000197	0.00291	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—glaucoma	0.000197	0.00291	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SMO—glaucoma	0.000194	0.00287	CbGpPWpGaD
Fluoxymesterone—Progesterone—NR3C1—glaucoma	0.00019	0.0206	CrCbGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—CDKN1B—glaucoma	0.000186	0.00276	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000185	0.00274	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000183	0.00271	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—FAS—glaucoma	0.000183	0.00271	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CDKN1B—glaucoma	0.000182	0.00269	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000181	0.00269	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CDKN1B—glaucoma	0.000179	0.00265	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000178	0.00263	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000178	0.00263	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NTRK2—glaucoma	0.000177	0.00263	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000175	0.00259	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—NR3C1—glaucoma	0.000174	0.0188	CrCbGaD
Fluoxymesterone—PRLR—Immune System—C3—glaucoma	0.000173	0.00256	CbGpPWpGaD
Fluoxymesterone—Betamethasone—PTGS2—glaucoma	0.00017	0.0184	CrCbGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—glaucoma	0.000169	0.0025	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MMP9—glaucoma	0.000168	0.0025	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MMP9—glaucoma	0.000166	0.00246	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—BCL2L1—glaucoma	0.000165	0.00245	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—NGF—glaucoma	0.000164	0.00243	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000161	0.00238	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.00016	0.00237	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000157	0.00232	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NGFR—glaucoma	0.000152	0.00225	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000152	0.00225	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—BAD—glaucoma	0.00015	0.00222	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NTRK1—glaucoma	0.000145	0.00214	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000141	0.00209	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—BAD—glaucoma	0.00014	0.00208	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000137	0.00203	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN2B—glaucoma	0.000133	0.00197	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EDN1—glaucoma	0.000128	0.00189	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NGF—glaucoma	0.000117	0.00174	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000117	0.00173	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LRP12—glaucoma	0.000116	0.00171	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—glaucoma	0.000114	0.00169	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—glaucoma	0.000113	0.00167	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—C3—glaucoma	0.000112	0.00165	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000112	0.00165	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000106	0.00157	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000106	0.00157	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDKN1B—glaucoma	0.000104	0.00155	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOE—glaucoma	0.000104	0.00154	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CDKN2B—glaucoma	0.000104	0.00154	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000103	0.00153	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CAV1—glaucoma	0.000103	0.00153	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—glaucoma	9.92e-05	0.00147	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PTGS2—glaucoma	9.87e-05	0.0107	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—FN1—glaucoma	9.81e-05	0.00145	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CDKN1B—glaucoma	9.78e-05	0.00145	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—BAD—glaucoma	9.69e-05	0.00144	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NR3C1—glaucoma	9.1e-05	0.00135	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—glaucoma	8.86e-05	0.00131	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	8.8e-05	0.0013	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	8.6e-05	0.00127	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	8.18e-05	0.00121	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	8.15e-05	0.00121	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—glaucoma	8.02e-05	0.00119	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—OPN4—glaucoma	8.02e-05	0.00119	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CDKN2B—glaucoma	7.99e-05	0.00118	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CDKN2B—glaucoma	7.87e-05	0.00117	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—glaucoma	7.85e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOS3—glaucoma	7.79e-05	0.00115	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—glaucoma	7.78e-05	0.00115	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	7.54e-05	0.00112	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HEYL—glaucoma	7.46e-05	0.0011	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTGFR—glaucoma	7.22e-05	0.00107	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR3C1—glaucoma	7.01e-05	0.00104	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	6.78e-05	0.001	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1B—glaucoma	6.75e-05	0.000999	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—glaucoma	6.73e-05	0.000996	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	6.65e-05	0.000984	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—glaucoma	6.25e-05	0.000926	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—glaucoma	6.18e-05	0.000915	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.81e-05	0.00086	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RPTOR—glaucoma	5.65e-05	0.000837	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—glaucoma	5.61e-05	0.000831	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NCK2—glaucoma	5.47e-05	0.000811	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	5.12e-05	0.000758	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CDKN2B—glaucoma	4.99e-05	0.00074	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HDAC9—glaucoma	4.65e-05	0.000689	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR3C1—glaucoma	4.38e-05	0.000649	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—glaucoma	4.24e-05	0.000628	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CDKN2B—glaucoma	3.85e-05	0.00057	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CDKN2B—glaucoma	3.79e-05	0.000561	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SMO—glaucoma	3.64e-05	0.000539	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR3C1—glaucoma	3.38e-05	0.0005	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NTRK2—glaucoma	3.33e-05	0.000493	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NGFR—glaucoma	2.86e-05	0.000423	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NTRK1—glaucoma	2.71e-05	0.000402	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN2B—glaucoma	2.5e-05	0.000371	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EDN1—glaucoma	2.4e-05	0.000356	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NGF—glaucoma	2.21e-05	0.000327	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—C3—glaucoma	2.1e-05	0.000311	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOE—glaucoma	1.95e-05	0.000289	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CAV1—glaucoma	1.93e-05	0.000287	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FN1—glaucoma	1.84e-05	0.000273	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BAD—glaucoma	1.82e-05	0.000269	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOS3—glaucoma	1.46e-05	0.000217	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1B—glaucoma	1.27e-05	0.000188	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—glaucoma	1.17e-05	0.000174	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—glaucoma	1.05e-05	0.000156	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—glaucoma	7.96e-06	0.000118	CbGpPWpGaD
